Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN10232550
ISRCTN10232550
Completed
未知

Intramuscular oxytocics: a multi-centre randomised comparison study of intramuscular carbetocin, syntocinon and syntometrine for the third stage of labour following vaginal birth

orth Bristol NHS Trust0 sites5,717 target enrollmentMarch 6, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSpecialty: Reproductive health and childbirth, Primary sub-specialty: Reproductive and Sexual MedicineUKCRC code/ Disease: Reproductive Health and Childbirth/ Complications of labour and deliveryPregnancy and ChildbirthReproductive Health and Childbirth/ Complications of labour and delivery

Overview

Phase
未知
Intervention
Not specified
Conditions
Specialty: Reproductive health and childbirth, Primary sub-specialty: Reproductive and Sexual Medicine
Sponsor
orth Bristol NHS Trust
Enrollment
5717
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2019 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/30606246

Registry
who.int
Start Date
March 6, 2018
End Date
September 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
orth Bristol NHS Trust

Eligibility Criteria

Inclusion Criteria

  • •Current inclusion criteria as of 27/06/2018:
  • •1\. \=18 years of age at time of delivery
  • •2\. Vaginal birth
  • •3\. Live, singleton pregnancy
  • •4\. \>24 weeks gestation
  • •Previous inclusion criteria:
  • •1\. \=18 years of age at time of baby’s birth
  • •2\. Planning to have a vaginal birth (spontaneous and instrumental)
  • •3\. Singleton pregnancy
  • •4\. Any gestational age

Exclusion Criteria

  • •Current exclusion criteria as of 27/06/2018:
  • •1\. Significant antepartum haemorrhage (\>50ml) or suspected or proven placenta abruption
  • •2\. Maternal coagulation disorder
  • •3\. Women who would decline blood products if required
  • •4\. Known or suspected hypertensive disorders
  • •5\. Peripheral, hepatic or cardiac disease
  • •6\. Epilepsy
  • •7\. Patients with an allergy or hypersensitivity to any of the active ingredients of the study drugs
  • •Previous exclusion criteria:
  • •1\. Significant antepartum haemorrhage (\>50ml) or suspected or proven placenta abruption

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A study comparing three drugs given immediately after child birth, used to prevent excessive maternal bleeding (post-partum haemorrhage).
EUCTR2014-001948-37-GBorth Bristol NHS Trust6,285
Withdrawn
Phase 2
A Pilot Feasibility Study of IM OXT on Fear of Pain and Trust in Physical Therapist During OP Rehabilitation After TKAOsteoarthritis, Knee
NCT04493229Wake Forest University Health Sciences
Completed
Not Applicable
A study to compare the effectiveness of intravenous oxytocin with intramuscular oxytocin given at the third stage of labour at preventing bleeding at vaginal birthPostpartum haemorrhage following vaginal deliveryPregnancy and Childbirth
ISRCTN14718882Coombe Women and Infants University Hospital1,000
Completed
Not Applicable
Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in GhanaPostpartum Hemorrhage
NCT01108289Johns Hopkins Bloomberg School of Public Health1,586
Completed
Not Applicable
A randomised controlled trial of oxytocin bolus versus oxytocin bolus and infusion for the control of blood loss at elective caesarean sectioStudy of blood loss at caesarean section associated with different use of oxytocinSigns and SymptomsControl of blood loss
ISRCTN17813715Health Research Board of Ireland (Ireland)2,069